Menu

Experience

Bill Boyle

    • Ethos Valuation Climbs to $2.7 Billion With New Capital Raise 


    • Lyell Immunopharma – $425 Million IPO 


    • Ethos Hits $2 Billion Valuation With Series D Round 


    • Meesho’s Valuation Reaches $2.1 Billion With Latest Funding Round 


    • Clearlake Capital Acquires Perforce Software and ProVation Medical 


    • GeneWEAVE Biosciences sale to Roche Molecular Diagnostic 


    • Jazz Pharmaceuticals – $575 Million Exchangeable Senior Note Offering